Understanding Glaucoma with Advanced Tools

Multiomic Framework for Glaucoma

NIH-funded research Icahn School of Medicine at Mount Sinai · NIH-11187212

This project looks at blood samples and genetic information from people with and without glaucoma to better understand what causes this eye condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11187212 on NIH RePORTER

What this research studies

Glaucoma is a serious eye disease that can lead to permanent vision loss. Our team is examining proteins and other small molecules found in blood plasma, along with genetic factors, to uncover how they contribute to glaucoma. We are also using artificial intelligence to identify different types of glaucoma based on patterns of vision loss. This work involves analyzing existing samples and data from large health studies to gain a deeper understanding of the disease's origins.

Who could benefit from this research

Good fit: This research uses existing blood samples and data from large health studies, so direct patient recruitment for new samples is not part of this specific grant.

Not a fit: Patients not affected by primary open-angle glaucoma or those not part of the Nurses' Health Study or Health Professionals Follow-up Study cohorts would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to earlier detection and more personalized treatments for glaucoma, potentially preventing vision loss for many patients.

How similar studies have performed: While individual components like proteomic and metabolomic analyses have been used in other diseases, combining them with genetic data and AI for glaucoma subtypes in this multiomic framework is a cutting-edge approach.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.